BIORA THERAPEUTICS, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)

Item 3.03. Material Modification to Rights of Security Holders.

The disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal

           Year.

On January 9, 2023, Biora Therapeutics, Inc. (the "Company") filed a Certificate of Elimination of Series X Preferred Stock (the "Certificate of Elimination") with the Secretary of State of the State of Delaware, which, effective immediately upon filing, eliminated all matters set forth in the Certificate of Designation of Series X Preferred Stock filed with the Secretary of State of the State of Delaware on November 21, 2022.

The foregoing description of the Certificate of Elimination does not purport to be complete and is subject to and qualified in its entirety by reference to the Certificate of Elimination, a copy of which is attached hereto as Exhibit 3.1, and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

3.1       Certificate of Elimination of Series X Preferred Stock

104     Cover Page Interactive Data File (formatted in Inline XBRL and contained
        in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses